Literature DB >> 33711079

Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level.

Anthony Ming-Yu Chuang1,2, Mau T Nguyen1,2, Ehsan Khan1,2, Dylan Jones1,2, Matthew Horsfall1, Sam Lehman1,2, Nathaniel R Smilowitz3, Kristina Lambrakis1,2, Martin Than4, Julian Vaile1,2, Ajay Sinhal1,2, John K French5,6, Derek P Chew1,2.   

Abstract

BACKGROUND: The Fourth Universal Definition of Myocardial Infarction (MI) differentiates MI from myocardial injury. We characterised the temporal course of cardiac and non-cardiac outcomes associated with MI, acute and chronic myocardial injury.
METHODS: We included all patients presenting to public emergency departments in South Australia between June 2011-Sept 2019. Episodes of care (EOCs) were classified into 5 groups based on high-sensitivity troponin-T (hs-cTnT) and diagnostic codes: 1) Acute MI [rise/fall in hs-cTnT and primary diagnosis of acute coronary syndrome], 2) Acute myocardial injury with coronary artery disease (CAD) [rise/fall in hs-cTnT and diagnosis of CAD], 3) Acute myocardial injury without CAD [rise/fall in hs-cTnT without diagnosis of CAD], 4) Chronic myocardial injury [elevated hs-cTnT without rise/fall], and 5) No myocardial injury. Multivariable flexible parametric models were used to characterize the temporal hazard of death, MI, heart failure (HF), and ventricular arrhythmia.
RESULTS: 372,310 EOCs (218,878 individuals) were included: acute MI (19,052 [5.12%]), acute myocardial injury with CAD (6,928 [1.86%]), acute myocardial injury without CAD (32,231 [8.66%]), chronic myocardial injury (55,056 [14.79%]), and no myocardial injury (259,043 [69.58%]). We observed an early hazard of MI and HF after acute MI and acute myocardial injury with CAD. In contrast, subsequent MI risk was lower and more constant in patients with acute injury without CAD or chronic injury. All patterns of myocardial injury were associated with significantly higher risk of all-cause mortality and ventricular arrhythmia.
CONCLUSIONS: Different patterns of myocardial injury were associated with divergent profiles of subsequent cardiac and non-cardiac risk. The therapeutic approach and modifiability of such excess risks require further research.

Entities:  

Year:  2021        PMID: 33711079      PMCID: PMC7954292          DOI: 10.1371/journal.pone.0248289

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  37 in total

1.  Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.

Authors:  Patrick Royston; Mahesh K B Parmar
Journal:  Stat Med       Date:  2002-08-15       Impact factor: 2.373

2.  How to use high-sensitivity cardiac troponins in acute cardiac care.

Authors:  Kristian Thygesen; Johannes Mair; Evangelos Giannitsis; Christian Mueller; Bertil Lindahl; Stefan Blankenberg; Kurt Huber; Mario Plebani; Luigi M Biasucci; Marco Tubaro; Paul Collinson; Per Venge; Yonathan Hasin; Marcello Galvani; Wolfgang Koenig; Christian Hamm; Joseph S Alpert; Hugo Katus; Allan S Jaffe
Journal:  Eur Heart J       Date:  2012-06-21       Impact factor: 29.983

3.  Fourth Universal Definition of Myocardial Infarction (2018).

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Bernard R Chaitman; Jeroen J Bax; David A Morrow; Harvey D White
Journal:  Circulation       Date:  2018-11-13       Impact factor: 29.690

4.  Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis.

Authors:  Tobias Reichlin; Raphael Twerenbold; Miriam Reiter; Stephan Steuer; Stefano Bassetti; Cathrin Balmelli; Katrin Winkler; Sabine Kurz; Claudia Stelzig; Michael Freese; Beatrice Drexler; Philip Haaf; Christa Zellweger; Stefan Osswald; Christian Mueller
Journal:  Am J Med       Date:  2012-12       Impact factor: 4.965

Review 5.  Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary.

Authors:  Joseph S Alpert; Kristian A Thygesen; Harvey D White; Allan S Jaffe
Journal:  Am J Med       Date:  2013-10-16       Impact factor: 4.965

6.  Elevated baseline cardiac troponin levels in the elderly - another variable to consider?

Authors:  Ian G Webb; S T Yam; Russel Cooke; Andrew Aitken; Peter D Larsen; Scott A Harding
Journal:  Heart Lung Circ       Date:  2014-08-05       Impact factor: 2.975

7.  A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: Design of the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T (RAPID-TnT) study.

Authors:  Cynthia Papendick; Andrew Blyth; Anil Seshadri; Michael J R Edmonds; Tom Briffa; Louise Cullen; Stephen Quinn; Jon Karnon; Anthony Chuang; Adam J Nelson; Matthew Horsfall; Erin Morton; Derek P Chew
Journal:  Am Heart J       Date:  2017-05-18       Impact factor: 4.749

8.  Sensitive troponin assay and the classification of myocardial infarction.

Authors:  Anoop S V Shah; David A McAllister; Rosamund Mills; Kuan Ken Lee; Antonia M D Churchhouse; Kathryn M Fleming; Elizabeth Layden; Atul Anand; Omar Fersia; Nikhil V Joshi; Simon Walker; Allan S Jaffe; Keith A A Fox; David E Newby; Nicholas L Mills
Journal:  Am J Med       Date:  2014-11-28       Impact factor: 4.965

9.  Isolated cardiac troponin rise does not modify the prognosis in elderly patients with hip fracture.

Authors:  Hélène Vallet; Alice Breining; Yannick Le Manach; Judith Cohen-Bittan; Anthony Mézière; Mathieu Raux; Marc Verny; Bruno Riou; Frédéric Khiami; Jacques Boddaert
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

10.  Association between troponin-I levels and outcome in critically ill patients admitted to non-cardiac intensive care unit with high prevalence of cardiovascular risk factors.

Authors:  Abdulaleem Alatassi; Mohamad Habbal; Hani Tamim; Musharaf Sadat; Eman Al Qasim; Yaseen M Arabi
Journal:  BMC Anesthesiol       Date:  2018-05-22       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.